Terms: = Ovarian cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB
255 results:
1. Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent ovarian cancer With
Lorusso D; Raspagliesi F; Ronzulli D; Valabrega G; Colombo N; Pisano C; Cassani C; Tognon G; Tamberi S; Mangili G; Mammoliti S; De Giorgi U; Greco F; Mosconi AM; Breda E; Artioli G; Andreetta C; Casanova C; Ceccherini R; Frassoldati A; Salutari V; Giolitto S; Scambia G
J Clin Oncol; 2024 May; 42(13):1488-1498. PubMed ID: 38315944
[TBL] [Abstract] [Full Text] [Related]
2. An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer.
Zhu K; Ma J; Tian Y; Liu Q; Zhang J
BMC Womens Health; 2024 Jan; 24(1):49. PubMed ID: 38238671
[TBL] [Abstract] [Full Text] [Related]
3. Estimating risk of endometrial malignancy and other intracavitary uterine pathology in women without abnormal uterine bleeding using IETA-1 multinomial regression model: validation study.
Heremans R; Wynants L; Valentin L; Leone FPG; Pascual MA; Fruscio R; Testa AC; Buonomo F; Guerriero S; Epstein E; Bourne T; Timmerman D; Van den Bosch T;
Ultrasound Obstet Gynecol; 2024 Apr; 63(4):556-563. PubMed ID: 37927006
[TBL] [Abstract] [Full Text] [Related]
4. Characteristics and survival of patients with gynecological cancers who refuse radiotherapy: a retrospective cohort study.
Zhang S; He J; Liu J
BMC Womens Health; 2023 Nov; 23(1):562. PubMed ID: 37915037
[TBL] [Abstract] [Full Text] [Related]
5. Risk factors for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3004).
Kim NK; Kim Y; Kim HS; Park SJ; Hwang DW; Lee SJ; Yoo JG; Chang SJ; Son JH; Kong TW; Kim J; Shim SH; Lee AJ; Suh DH; Lee YY
Cancer Med; 2023 Oct; 12(19):19449-19459. PubMed ID: 37768030
[TBL] [Abstract] [Full Text] [Related]
6. Ultra-Processed Food Consumption and Mortality: Three Cohort Studies in the United States and United Kingdom.
Zhao Y; Chen W; Li J; Yi J; Song X; Ni Y; Zhu S; Zhang Z; Xia L; Zhang J; Yang S; Ni J; Lu H; Wang Z; Nie S; Liu L
Am J Prev Med; 2024 Feb; 66(2):315-323. PubMed ID: 37690589
[TBL] [Abstract] [Full Text] [Related]
7. Deep epigastric lymph nodes implication in patients' recurrence pattern after cytoreductive surgery in ovarian peritoneal metastases.
El Asmar A; Vouche M; Pop F; Polastro L; Chintinne M; Veys I; Donckier V; Liberale G
Eur J Surg Oncol; 2023 Sep; 49(9):106911. PubMed ID: 37149402
[TBL] [Abstract] [Full Text] [Related]
8. Radiologically enlarged cardiophrenic lymph nodes and CA-125 in relation to diaphragmatic carcinomatosis, surgical outcome, and overall survival in advanced ovarian cancer.
Plana A; Talo R; Wallengren NO; Pudaric S; Sartor H; Asp M
Acta Oncol; 2023 May; 62(5):451-457. PubMed ID: 37129994
[TBL] [Abstract] [Full Text] [Related]
9. Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study.
Goldsbury DE; Vassallo A; Weber MF; Steinberg J; Webb PM; DeFazio A; Canfell K
PLoS One; 2023; 18(4):e0282851. PubMed ID: 37071628
[TBL] [Abstract] [Full Text] [Related]
10. Effects of needle puncturing on re-vascularization and follicle survival in xenotransplanted human ovarian tissue.
Olesen HØ; Pors SE; Adrados CS; Zeuthen MC; Mamsen LS; Pedersen AT; Kristensen SG
Reprod Biol Endocrinol; 2023 Mar; 21(1):28. PubMed ID: 36941662
[TBL] [Abstract] [Full Text] [Related]
11. Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer.
Foster KI; Shaw KRM; Jin J; Westin SN; Yap TA; Glassman DM; Jazaeri AA; Rauh-Hain JA; Lee S; Fellman BM; Ju Z; Liu Y; Fleming ND; Sood AK
Cancer; 2023 Jun; 129(11):1672-1680. PubMed ID: 36930815
[TBL] [Abstract] [Full Text] [Related]
12. The Impact of Sarcopenia Onset Prior to cancer Diagnosis on cancer Survival: A National Population-Based Cohort Study Using Propensity Score Matching.
Su CH; Chen WM; Chen MC; Shia BC; Wu SY
Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904245
[TBL] [Abstract] [Full Text] [Related]
13. A prospective cohort study of infertility and cancer incidence.
Wang S; Gaskins AJ; Farland LV; Zhang D; Birmann BM; Rich-Edwards JW; Wang YX; Tamimi RM; Missmer SA; Chavarro JE
Fertil Steril; 2023 Jul; 120(1):134-142. PubMed ID: 36849034
[TBL] [Abstract] [Full Text] [Related]
14. Wnt Family Member 9b (Wnt9b) Is a Sensitive and Specific Marker for Triple-negative Breast Carcinoma Including Metaplastic Carcinoma.
Shaker N; Shafi S; Parkinson B; Chen W; Parwani AV; Ding Q; Li Z
Am J Surg Pathol; 2023 Jan; 47(1):47-54. PubMed ID: 36525542
[TBL] [Abstract] [Full Text] [Related]
15. Analysis of the Safety and Pregnancy Outcomes of Fertility-sparing Surgery in ovarian Malignant Sex Cord-stromal Tumours: A Multicentre Retrospective Study.
Li J; Chu R; Wang Z; Chen G; Shen Y; Lou Y; Li L; Sun C; Li K; Song L; Qin T; Li J; Yin Y; Chen Z; Liu P; Song K; Kong B
Clin Oncol (R Coll Radiol); 2023 Feb; 35(2):e206-e214. PubMed ID: 36494251
[TBL] [Abstract] [Full Text] [Related]
16. Investigation of cytotoxic and apoptotic effects of disodium pentaborate decahydrate on ovarian cancer cells and assessment of gene profiling.
Gunel NS; Yildirim N; Ozates NP; Oktay LM; Bagca BG; Sogutlu F; Ozsaran A; Korkmaz M; Biray Avci C
Med Oncol; 2022 Oct; 40(1):8. PubMed ID: 36308567
[TBL] [Abstract] [Full Text] [Related]
17. Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification.
Thompson EF; Huvila J; Jamieson A; Leung S; Lum A; Offman S; Lytwyn A; Sur ML; Hoang L; Irving J; van der Westhuizen N; Morin C; Bicamumpaka C; Azordegan N; Gougeon F; Ennour-Idrissi K; Senz J; McConechy MK; Aguirre-Hernandez R; Lui V; Kuo C; Bell C; Salisbury T; Lawson J; He E; Wang S; Chiu D; Kean S; Samouëlian V; Salvador S; Gotlieb W; Helpman L; Scott S; Wohlmuth C; Vicus D; Plante M; Talhouk A; Huntsman D; Parra-Herran C; Kinloch M; Grondin K; Gilks CB; McAlpine JN;
Mod Pathol; 2022 Dec; 35(12):1974-1982. PubMed ID: 36241860
[TBL] [Abstract] [Full Text] [Related]
18. cancer risks associated with heterozygous ATM loss of function and missense pathogenic variants based on multigene panel analysis.
Laitman Y; Nielsen SM; Bernstein-Molho R; Heald B; Hatchell KE; Esplin ED; Friedman E
Breast Cancer Res Treat; 2022 Nov; 196(2):355-361. PubMed ID: 36094610
[TBL] [Abstract] [Full Text] [Related]
19. Modulation of intracellular kinase signaling to improve TIL stemness and function for adoptive cell therapy.
Feng H; Qiu L; Shi Z; Sheng Y; Zhao P; Zhou D; Li F; Yu H; You Y; Wang H; Li M; Zhu S; Du Y; Cui J; Sun J; Liu Y; Jiang H; Wu X
Cancer Med; 2023 Feb; 12(3):3313-3327. PubMed ID: 36028997
[TBL] [Abstract] [Full Text] [Related]
20. Association between Rheumatoid Arthritis Disease Activity and Risk of ovarian Malignancy in Middle-Aged and Elderly Women.
Huang Z; Tan L; Ling Y; Huang F; Ma W
Biomed Res Int; 2022; 2022():1062703. PubMed ID: 35663045
[TBL] [Abstract] [Full Text] [Related]
[Next]
